Evaluation of the Evolution of Imaging Markers of Cartilage Degradation in Patients With Knee Osteoarthritis Receiving DROGLICAN

NCT02821468 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis, Knee

Interventions

DRUG: Droglican
DRUG: Paracetamol or oral NSAIDs excluding COX2 inhibitors

Sponsor

Bioiberica

Collaborators

[object Object]